Navigation Links
Touch Bionics unveils innovative partner and reimbursement programs at AOPA
Date:9/10/2008

New programs designed to support the growing number of US clinics

CHICAGO, IL, Sept. 10 /PRNewswire/ - Touch Bionics, developer of the world's first commercially available bionic hand, today revealed details of two new support programs at the 2008 National Assembly of the American Orthotic and Prosthetic Association (AOPA). Set to commence on November 3, 2008, the company's RACE Team and Partner Program are designed to provide additional support to the growing number of prosthetics clinics that are now offering the i-LIMB Hand to their patients.

RACE Team

Touch Bionics' Reimbursement Assistance & Clinical Evaluation (RACE) Team is designed to assist O&P facilities with their reimbursement efforts on the i-LIMB Hand and LIVINGSKIN passive prosthesis. Over the first 12 months of sales of the i-LIMB Hand, Touch Bionics has assembled a wealth of information and understanding on obtaining reimbursement approvals, and the creation of the RACE Team demonstrates the company's willingness to share this knowledge with its clinical customers and partners.

The RACE Team will provide services to practitioners, including a complete packet of up-to-date reimbursement information regarding the i-LIMB Hand and LIVINGSKIN, as well as a new monthly rental program for the hand. The RACE Team will also provide detailed presentation materials, a customized patient evaluation process over the telephone, and billing support with deferred payments on Touch Bionics' products.

"Reimbursement is a big concern for patients and clinics alike and, with the RACE Team, we are addressing this collective challenge head on," said Mark Ford, U.S. sales and marketing director, Touch Bionics. "The RACE Team comprises a combination of experienced full-time staff and contracted consultants to provide the best possible level of reimbursement-related support."

Touch Bionics' RACE Team includes personnel with extensive clinical, reimbursement, billing and contr
'/>"/>

SOURCE TOUCH BIONICS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
2. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
3. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
4. Touch Bionics adds to sales, marketing, production and design teams
5. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
6. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
7. Touch Bionics signs U.S. distribution agreement with SPS
8. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
9. Touch Bionics appoints Head of Clinical Advocacy
10. Touch Bionics acquires LIVINGSKIN
11. Touch Bionics wins the 2008 MacRobert Award - i-LIMB Hand recognised as the leading engineering innovation of the year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Global Synthetic Biology Market 2014-2018" report ... The term synthetic biology covers the ... and organisms as well as the redesigning of natural ... is considered to be a form of extreme genetic ...
(Date:7/28/2014)... 28, 2014  David Hardison, Ph.D., vice president ... , has been elected chairman of the board ... non-profit working to establish common protocols around the ... relates to electronic health records. ... collaborating with organizations across the research and health ...
(Date:7/28/2014)... Appistry, Inc. , a leading ... power of genomics to next-generation medicine, announced today its ... . , Two Appistry staff will be joined ... for Genome Resources, and Mr. Neil Miller, director of ... City. Rounding out the panel are Appistry’s Dr. Richard ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... its second quarter 2014 financial results at the close ... live conference call and webcast will be hosted by ... Interested investors and others may participate in ... 212-231-2900 (international), conference ID#21728775. A replay of the webcast and ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2InterMune to Release Second Quarter Financial Results on August 6 2
... Pharmaceuticals, a,division of Wyeth (NYSE: WYE ... for XYNTHA(TM) Antihemophilic Factor (Recombinant),Plasma/Albumin-Free, a new ... and prevention of bleeding episodes and surgical ... inherited blood-clotting disorder., XYNTHA is produced ...
... Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that that it ... trial using intravenous,administration of REOLYSIN(R) in combination with ... neck cancers. The Principal,Investigator is Dr. Monica Mita ... The University of Texas Health Science Center at ...
... Senior-friendly ,PlanPrescriber, Software Simplifies Medicare - For Free, ... today,announced the latest release of their PlanPrescriber tool. ... worry about whether they are,getting the most out ... MIT Professor Glen Urban, provides users with easy ...
Cached Biology Technology:New Recombinant XYNTHA Now Available for Patients with Hemophilia A 2New Recombinant XYNTHA Now Available for Patients with Hemophilia A 3New Recombinant XYNTHA Now Available for Patients with Hemophilia A 4New Recombinant XYNTHA Now Available for Patients with Hemophilia A 5Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3On-Line Medicare Advisor Saves Seniors Time, Hassle and Money 2
(Date:7/28/2014)... rat brain cells suggests that the effects of a ... cells are temporary. , The study, published in this ... was conducted by biologists at the University of California, ... York in response to concerns, arising from multiple studies ... to general anesthetics may increase their susceptibility to long-term ...
(Date:7/28/2014)... identified areas of the Earth that are high priorities ... Europe is particularly vulnerable, as it has the lowest ... of any continent in ,refugia, areas of biological ... remain relatively constant during times of great environmental change. ... in Scandinavia and Scotland. , The biggest refugia ...
(Date:7/28/2014)... advance the genetic engineering of "fuel" crops for ... by researchers with the U.S. Department of Energy ... led by Lawrence Berkeley National Laboratory (Berkeley Lab). ... enables scientists to identify and characterize the function ... biosynthesis of plant cell walls. , "Our unique ...
Breaking Biology News(10 mins):Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2How sweet it is 2How sweet it is 3
... , ASHEVILLE, NC A recent analysis of two ... (FIA) data shows the live volume of hemlocks in ... of hemlock woolly adelgid. FIA scientists from the Forest ... (NRS) published the information as an SRS e-Science Update ...
... laboratory mice have been widely used in research aimed at ... variations in past gene sequences of mice were unknown. While ... was in a certain region, they couldn,t pinpoint the exact ... new research recently published in the journal Nature , ...
... 2011Magnetic resonance tractography (MRT) is a valuable, noninvasive ... as MRT methods and technologies advance, has the ... brain activity and connectivity. Critical information about the ... in a forward-looking review article in the groundbreaking ...
Cached Biology News:Hemlocks still abundant despite adelgid infestations 2UCLA Engineering researchers help develop complete map of mouse genetic variation 2
... PhosphoPlus™ SAPK/JNK (Thr183/Tyr185) Antibody Kit ... Antibody, Catalog #9251, 200 ul SAPK/JNK ... ul SAPK/JNK Cell Extracts, Catalog #9253, ... Antibody, Catalog #7074, 100 ul Anti-biotin ...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
...
Anti-human Carcinoma Associated Antigen, Clone 115D8, Monoclonal Antibody Innate Immunity - Tumor Markers...
Biology Products: